Complications After CT-guided Lung Biopsies at St. Olavs Hospital

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07528170

Acronym

KELSO

Enrollment

1200

Registered

2026-04-14

Start date

2012-05-01

Completion date

2023-12-31

Last updated

2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Air Embolism as A Complication of Medical Care, Hemoptysis, Pneumothorax Iatrogenic Postprocedural

Keywords

Lung cancer, CT-guided lung biopsy

Brief summary

At St. Olavs Hospital, a prospective collection of data on complications related to CT-guided lung biopsies has been conducted over several years as part of quality control study. The primary aim of this quality control study is to map complications in all patients who have undergone percutaneous CT-guided lung biopsy at St. Olavs Hospital from May 2012 to December 2023.

Interventions

PROCEDURECT-guided needle biopsy of lung nodule

This is a simple needle biopsy of lung nodules guided with CT imaging

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients eligible to a CT-guided needle biopsy of a lung nodule (allcomers)

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Pneumothorax	Patients are assessed with a CT scan 5 minutes after the lung biopsy	The frequency of pneumothorax after lung biopsy
Lung bleeding	Patiens are assessed with a CT scan 5 minutes after the procedure	How frequent is parenchymal bleeding after lung biopsy

Secondary

Measure	Time frame	Description
Factors associated with complications after lung biopsy	All patiens are assessed with CT scan 5 minutes after the lung biopsy	Analyse possible factors leading to complications after lung biopsies

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026